![University of Warwick](/images/warwick_uni_black.gif)
The Library
Browse by Department at the University of Warwick
![]() | Up a level |
Number of items: 16.
B
Balmer, Claire E., Dunn, Janet A. and Griffiths, Frances (2010) Using photography to find out about the needs of often neglected populations. In: INVOLVE Conference 2010, 2010
Brown, Janet E., Sherriff, Jennifer M. and James, Nicholas D. (2010) Osteoporosis in patients with prostate cancer on long-term androgen deprivation therapy : an increasing, but under-recognized problem. BJU International, 105 (8). pp. 1042-1043. doi:10.1111/j.1464-410X.2010.09251.x ISSN 1464-1603.
Bryan, Richard T., Zeegers, Maurice P., James, Nicholas D., Wallace, D. Michael A. and Cheng, Kar Keung (2010) Biomarkers in bladder cancer. BJU International, 105 (5). pp. 608-613. doi:10.1111/j.1464-410X.2009.08880.x ISSN 1464-1603.
C
Cathomas, Richard, Helbling, Daniel, Stenner, Frank, Rothermundt, Christian, Rentsch, Cyrill, Shahin, Osama, Seifert, Hans-Helge, Zaugg, Kathrin, Lorch, Anja, Mayer, Frank, Beyer, Jรถrg, De Santis, Maria and Gillessen, Silke (2010) Interdisciplinary evidence-based recommendations for the follow-up of testicular cancer patients : a joint effort. Swiss medical weekly, 140 (25-26). pp. 356-69. ISSN 1424-3997.
D
Daugaard, G., Skoneczna, I., Aass, N., De Wit, R., De Santis, Maria , Dumez, H., Marreaud, S., Collette, L., Lluch, J. R. G., Bokemeyer, C. and Schmoll, H. J. (2010) A randomized phase III study comparing standard dose BEP with sequential high-dose cisplatin, etoposide, and ifosfamide (VIP) plus stem-cell support in males with poor-prognosis germ-cell cancer. An intergroup study of EORTC, GTCSG, and Grupo Germinal (EORTC 30974). Annals of Oncology, Volume 22 (Number 5). pp. 1054-1061. doi:10.1093/annonc/mdq575 ISSN 0923-7534.
Dawson, Nancy, Payne, Heather, Battersby, Clare, Taboada, Maria and James, Nicholas D. (2010) Health-related quality of life in pain-free or mildly symptomatic patients with metastatic hormone-resistant prostate cancer following treatment with the specific endothelin A receptor antagonist zibotentan (ZD4054). Journal of Cancer Research and Clinical Oncology, 137 (1). pp. 99-113. doi:10.1007/s00432-010-0864-1 ISSN 0171-5216.
De Santis, Maria , Bachner, Mark, Lawrentschuk, N., Jack, G. S. and Bolton, D. M. (2010) Radiographic diagnosis and staging. In: Laguna, M. Pilar and Albers, Peter and Richie, Jerome P and Bokemeyer, Carsten, (eds.) Cancer of the Testis. London: Springer, pp. 75-94. ISBN 9781848003699
G
Gore, Martin E., Griffin, Clare L., Hancock, Barry, Patel, Poulam M., Pyle, Lynda, Aitchison, Michael, James, Nicholas D., Oliver, Roderick T. D., Mardiak, Jozef, Hussain, Tahera, Sylvester, Richard, Parmar, Mahesh K. B., Royston, Patrick and Mulders, Peter F. A. (2010) Interferon alfa-2a versus combination therapy with interferon alfa-2a, interleukin-2, and fluorouracil in patients with untreated metastatic renal cell carcinoma (MRC RE04/EORTC GU 30012) : an open-label randomised trial. The Lancet, 375 (9715). pp. 641-648. doi:10.1016/S0140-6736(09)61921-8 ISSN 0140-6736.
H
Guideline Development Group (Including: Hill, J. and Treasure, T.). (2010) Reducing the risk of venous thromboembolism (deep vein thrombosis and pulmonary embolism) in patients admitted to hospital : summary of the NICE guideline. Heart, 96 (11). pp. 879-882. doi:10.1136/hrt.2010.198275 ISSN 1355-6037.
Guideline Development Group (Including: Hill, J. and Treasure, T.). (2010) Reducing the risk of venous thromboembolism in patients admitted to hospital : summary of NICE guidance. BMJ, 340 . c95-c95. doi:10.1136/bmj.c95 ISSN 0959-535X.
J
James, Nicholas D., Caty, Armelle, Payne, Heather, Borre, Michael, Zonnenberg, Bernard A., Beuzeboc, Philippe, McIntosh, Stuart, Morris, Thomas, Phung, De and Dawson, Nancy A. (2010) Final safety and efficacy analysis of the specific endothelin A receptor antagonist zibotentan (ZD4054) in patients with metastatic castration-resistant prostate cancer and bone metastases who were pain-free or mildly symptomatic for pain: a double-blind, placebo-controlled, randomized Phase II trial. BJU International, 106 (7). pp. 966-973. doi:10.1111/j.1464-410X.2010.09638.x ISSN 1464-1603.
R
Rossi, J-F., Nรฉgrier, S., James, Nicholas D., Kocak, I., Hawkins, R., Davis, H., Prabhakar, U., Qin, X., Mulders, P. and Berns, B. (2010) A phase I/II study of siltuximab (CNTO 328), an anti-interleukin-6 monoclonal antibody, in metastatic renal cell cancer. British Journal of Cancer, 103 (8). pp. 1154-1162. doi:10.1038/sj.bjc.6605872 ISSN 0007-0920.
S
Sherriff, J. M., Brown, J. E. and James, Nicholas D. (2010) An under-recognised risk. BMJ, 340 (jan13 3). c143-c143. ISSN 0959-535X doi:10.1136/bmj.c143
Stanley, A. and Young, Annie M. (2010) Primary prevention of venous thromboembolism in medical and surgical oncology patients. British Journal of Cancer, 102 . S10-S16. doi:10.1038/sj.bjc.6605600 ISSN 0007-0920.
Stenzl, A., Cowan, N. C., De Santis, Maria, Jakse, G., Kuczyk, M. A., Merseburger, A. S., Ribal, M. J., Sherif, A. and Witjes, J. A. (2010) Actualizaciรณn de las Guรญas Clรญnicas de la Asociaciรณn Europea de Urologรญa sobre el carcinoma vesical mรบsculo-invasivo y metastรกsico. Actas Urologicas Espanolas, Volume 34 (Number 1). pp. 51-62. doi:10.1016/S0210-4806(10)70010-3 ISSN 1699-7980.
Z
Zeegers, Maurice P., Bryan, Richard T., Langford, Carolyn, Billingham, Lucinda, Murray, Paul, Deshmukh, Neeta S., Hussain, Syed, James, Nicholas D., Wallace, D. Michael A. and Cheng, K.K. (2010) The West Midlands bladder cancer prognosis programme : rationale and design. BJU International, 105 (6). pp. 784-788. doi:10.1111/j.1464-410X.2009.08849.x ISSN 1464-1603.